Myriad Pharmaceuticals Acquires Javelin Pharmaceuticals for Undisclosed Sum

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=44660082-8474-435e-a2e4-5e4b4f0c91fe&Preview=1
Date
12/21/2009
Company Name
Javelin Pharmaceuticals
Mailing Address
125 CambridgePark Drive Cambridge, MA 02140
Company Description
Javelin is a specialty pharmaceutical company that applies innovative proprietary delivery technologies to develop new, improved formulations of existing drugs that target unmet and underserved medical needs in the growing pain management market.
Website
http://www.javelinpharmaceuticals.com
Transaction Type
M&A
Transaction Amount
Undisclosed
Transaction Round
Proceeds Purposes
M&A Terms
The merger, which is expected to close in the first quarter of 2010, has been approved by the boards of both companies but must also be approved by the shareholders of each firm.